METHODS FOR THE USE OF CYCLIC AMIDE DERIVATIVES FOR TREATMENT OF SIGMA-RECEPTOR-MEDIATED DISORDERS Russian patent published in 2021 - IPC A61K31/445 A61P25/18 

Abstract RU 2746871 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, namely, to psychiatry and neurology and can be used in the treatment of dementia with Lewy bodies, bipolar disorder and hypomania. The methods of the invention comprise administering to a subject in need of treatment a therapeutically effective amount of a compound of Formula (II)

.

EFFECT: use of inventions makes it possible to improve cognition, sleep, reduce negative symptoms with minimal side effects.

12 cl, 2 ex

Similar patents RU2746871C2

Title Year Author Number
METHODS OF USING CYCLIC AMIDE DERIVATIVES FOR TREATING SIGMA-RECEPTOR MEDIATED DISORDERS 2011
RU2613201C2
METHODS FOR USING CYCLIC AMIDE DERIVATIVES FOR TREATING SCHIZOPHRENIA 2011
  • Lutringer Remi Anri
  • Pellegrini Lorentso
  • Karabelas Argeris N.
RU2576611C2
MIXTURE CONTAINING CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF SCHIZOPHRENIA 2018
  • Joung, Chan Mi
  • Hwang, Sun Gwan
  • Lee, Ji Won
  • Jang, Young Koo
RU2772465C2
NEW METHODS 2014
  • Vanover Kimberli
  • Li Pen
  • Mejts Sheron
  • Devis Robert
  • Uennogl Lourens P.
RU2682658C1
THERAPEUTIC AGENTS 2008
  • Bilodo Mark T.
  • Nanda Kausik K.
  • Trotter B. Uehsli
RU2468025C2
COMBINATIONS OF COMPOUNDS MODULATING THE NMDA RECEPTOR 2015
  • Moskal Dzhozef R.
RU2721948C2
TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 2014
  • Kenig Gerkhard
  • Chesuort Richard
  • Shapiro Gideon
RU2662560C2
USING ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISEASES, INCREASE NEUROPLASTICITY AND PROMOTE NEUROPROTECTION 2019
  • Luthringer, Remy Henri
RU2812786C2
THERAPEUTIC AGENT FOR TREATING NEUROLOGICAL BEHAVIOUR DISORDERS AND METHOD OF TREATING NEUROLOGICAL BEHAVIOUR DEVELOPMENT DISORDERS 2011
  • Ehpshtejn Oleg Il'Ich
RU2536230C2
TREATING COGNITIVE DISORDERS WITH (R)-7-CHLOR-N-(QUINUCLIDIN-3-YL) BENZO[b] THIOPHEN-2-CARBOXAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS 2009
  • Kenig Gerkhard
  • Chesuort Richard
  • Shapiro Gideon
RU2532327C2

RU 2 746 871 C2

Authors

Luthringer, Remy, Henri

Pellegrini, Lorenzo

Karabelas, Argeris, N.

Dates

2021-04-21Published

2011-07-20Filed